Lv4
610 积分 2022-02-13 加入
Targeting IL-6 trans-signalling: past, present and future prospects
1个月前
已完结
GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease
1个月前
已完结
Central regulation of the anorexigenic receptor GFRAL
2个月前
已完结
Definition and classification of cancer cachexia: an international consensus
2个月前
已完结
Cancer-associated cachexia — understanding the tumour macroenvironment and microenvironment to improve management
2个月前
已完结
Antisense drug discovery and development technology considered in a pharmacological context
3个月前
已完结
A Bayesian interval dose-finding design addressingOckham's razor: mTPI-2
4个月前
已完结
HLA common and well‐documented alleles in China
6个月前
已完结
PK/PD Evaluation of Antibody–Drug Conjugates with Enhanced Immune Effector Functions
6个月前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
7个月前
已完结
皖公网安备34019202002308
